Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment

Market Focus

2 hours ago

On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.

On the news front, the company was formally included in the CSI Index series effective the same day, covering the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Composite Index. Additionally, the company is set to be included in the FTSE Global Equity Index Series on June 22, covering the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index. The dual index inclusion is expected to attract passive fund inflows tracking these indices, enhance trading liquidity, and diversify the shareholder base, significantly improving short-term market sentiment.

However, approximately 453 million restricted shares held by cornerstone investors and employees will see their lock-up period expire on June 29, representing 81.25% of total share capital. Potential concentrated selling pressure remains a key concern going forward.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1150477327"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1150477327\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1150477327?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-15 09:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150477327","market":"us","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment","media":"Market Focus","content":"<p><p>On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.</p><p>On the news front, the company was formally included in the CSI Index series effective the same day, covering the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Composite Index. Additionally, the company is set to be included in the FTSE Global Equity Index Series on June 22, covering the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index. The dual index inclusion is expected to attract passive fund inflows tracking these indices, enhance trading liquidity, and diversify the shareholder base, significantly improving short-term market sentiment.</p><p>However, approximately 453 million restricted shares held by cornerstone investors and employees will see their lock-up period expire on June 29, representing 81.25% of total share capital. Potential concentrated selling pressure remains a key concern going forward.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Rises 5.61% in Regular Trading, Dual Index Inclusion Boosts Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-15 09:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.</p><p>On the news front, the company was formally included in the CSI Index series effective the same day, covering the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Composite Index. Additionally, the company is set to be included in the FTSE Global Equity Index Series on June 22, covering the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index. The dual index inclusion is expected to attract passive fund inflows tracking these indices, enhance trading liquidity, and diversify the shareholder base, significantly improving short-term market sentiment.</p><p>However, approximately 453 million restricted shares held by cornerstone investors and employees will see their lock-up period expire on June 29, representing 81.25% of total share capital. Potential concentrated selling pressure remains a key concern going forward.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1150477327","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150477327","pubTimestamp":1781487998,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.On the news front, the company was formally included in the CSI Index...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易涨5.61%双指数纳入提振人气","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 15, Insilico Medicine rose 5.61% in regular trading, trading at 36.36 HKD/share, with turnover of 31.75 million HKD.On the news front, the company was formally included in the CSI Index series effective the same day, covering the CSI Hong Kong Stock Connect Innovative Drug Index, CSI Hong Kong Innovative Drug Index, and CSI Hong Kong Stock Connect Healthcare Composite Index. Additionally, the company is set to be included in the FTSE Global Equity Index Series on June 22, covering the FTSE Global Small Cap Index, FTSE Global All Cap Index, and FTSE Global Total Cap Index. The dual index inclusion is expected to attract passive fund inflows tracking these indices, enhance trading liquidity, and diversify the shareholder base, significantly improving short-term market sentiment.However, approximately 453 million restricted shares held by cornerstone investors and employees will see their lock-up period expire on June 29, representing 81.25% of total share capital. Potential concentrated selling pressure remains a key concern going forward.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}